Management of depressive disorder. What treatment should be use?


Authors

DOI:

https://doi.org/10.22517/25395203.24637

Keywords:

Depression, Antidepressants, Pharmacological treatment, non-pharmacological interventions

Abstract

Throughout history, the human being has sought to improve and treat different mental pathologies, with advances in research, currently there is a wide variety of therapeutic options that can be a confounding factor when choosing the most appropriate treatment. This paper reviews the main treatment options for depression in order to provide guidelines that improve decision-making when addressing this pathology.

Downloads

Download data is not yet available.

Author Biographies

Juliana Vergel Hernández, Md., Universidad Libre – Seccional Cali

Médica.

Residente de Psiquiatría

Grupo Ciclo Vital

Universidad Libre – Seccional Cali

María Eugenia Barrera Robledo, Md., Universidad Libre – Seccional Cali

Médica.

Residente de Psiquiatría

Grupo Mente Sana

Universidad Libre – Seccional Cali

References

Organización Mundial de la Salud. Centro de prensa - Organizacion mundial de la salud. [Online] 2019 [cited Sep 02, 2019 Available from: https://www.who.int/es/news-room/fact-sheets/detail/suicide

Organización Mundial de la Salud. Datos y cifras Generalidades Tipos y síntomas, factores contribuyentes y prevención. [Online] 2013 [cited Aug 24, 2020. Available from: www.who.int/es/news-room/fact-sheets/detail/depression

Ministerio de Salud y Protección Social. Boletín de Salud Mental Depresión Bogotá. [Online] 2017 [cited Sep 02, 2019 Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/boletin-depresion-marzo-2017.pdf

American Psychiatric Association. Manual Diagnóstico y Estadístico de los Trastornos Mentales DSM 5. 5th ed. Madrid: Editoral Médica Panamericana; 2014.

Jiménez MA. Tratado de geriatría para residentes. 1st ed. Madrid: International Marketing & Communication, S.A.; 2006.

Palacio C, Toro A. Fundamentos de medicina Psiquiatria. 6th ed. Medellin: Ecoe ediciones; 2018.

Ministerio de Salud y Protección Social. Guía de Práctica Clínica (GPC) Detección temprana y diagnóstico del episodio depresivo y trastorno depresivo recurrente en adultos. Atención integral de los adultos con diagnóstico de episodio depresivo o trastorno depresivo recurrente. 1st ed. Bogota: Ministerio de Salud y Protección Social; 2013.

Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. 2016.

Fernández V. Fundamentos límites de la psicoterapia. In Fernández V. Boletín de la escuela de medicina, Pontificia Universidad católica de Chile. Santiago de Chile; 1994.

Garber J, Weersing VR. Comorbidity of Anxiety and Depression in Youth: Implications for Treatment and Prevention. Clin Psychol (New York). 2010 Dec;17(4):293-306. https://10.1111/j.1468-2850.2010.01221.x.

Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. https://10.1176/ajp.2006.163.11.1905.

Gómez R, Roca M, Gili M, García J. Estilo de vida saludable: un factor de protección minusvalorado frente a la depresión. Psiquiatría Biológica. 2017 Julio; 24(3).

David D, Gourion D. Antidepressant and tolerance: Determinants and management of major side effects. L'Encéphale. 2016; 42(6).

Clínica NINdSyE. El tratamiento y manejo de la depresión en adultos. NICE - National Clinical Practice Guideline. 2010.

Gao K, Muzina D, Gajwani P, Calabrese JR. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry. 2006 Sep;67(9):1327-40. https://10.4088/jcp.v67n0902. PMID: 17017818.

Cuijpers P, Cuijpers J, Hollon S, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry. 2009 ; 70(9).

Cipriani A, Furukawa T, Salanti G. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009; 373(9665).

Gibbons R, Hur K, Brown C. Beneficios de los antidepresivos: síntesis de resultados a nivel de paciente de 6 semanas de ensayos aleatorios doble ciego controlados con placebo de fluoxetina y venlafaxina. Arch Gen Psychiatry. 2012; 69(6).

Beyer J, Johnson K. Advances in Pharmacotherapy of Late-Life Depression. Current Psychiatry Rep. 2018; 20(34).

Andrade C. Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? J Clin Psychiatry. 2017 Jul;78(7):e852-e857. https://10.4088/JCP.17f11738. PMID: 28749092.

Pagnin D, Queiroz V, Pini S, Battista G. Efficacy of ECT in depression: a meta-analytic review. The Journal of ECT. 2004; 20(1).

Downloads

Published

2021-06-13

How to Cite

Vergel Hernández, J., & Barrera Robledo, M. E. (2021). Management of depressive disorder. What treatment should be use?. Revista Médica De Risaralda, 27(1). https://doi.org/10.22517/25395203.24637